<DOC>
	<DOCNO>NCT02725996</DOCNO>
	<brief_summary>To prove efficacy safety 'NK group ' superior 'non-treatment group ( Control group ) ' patient undergone curative resection ( RFA operation ) hepatocellular carcinoma China .</brief_summary>
	<brief_title>By Using Adoptive Transfer Autologous NK Cells Prevent Recurrence Hepatocellular Carcinoma After Curative Therapy</brief_title>
	<detailed_description>No adjuvant therapy show extend survival patient hepatocellular carcinoma receive curative treatment.We investigate whether injection NK cell prolong recurrence-free survival patient curative therapy .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Prior test , patient fully explain purpose/ content characteristic test medication , patient ( ) self , guardian legal representative sign write consent . 2 . Gender unlimited , age 18 year 70 year 3 . The patient diagnose hepatocellular carcinoma pathological/ radiological test ( ) stage I II . ( refer attach file 10 ) . Hepatocellular carcinoma show radiological test ; dynamic CT , dynamic MRI angiography . 4 . ChildPugh Score less 6 5 . No matter patient treat , ( ) tumor totally remove curative resection ( RFA operation ) . ( base agreement date write consent ) 6 . Patients must adequate cardiac function ( cardiac disease , LVEF≥40 % ) , adequate pulmonary function indicate room air oxygen saturation &gt; 94 % , adequate renal function ( Cr≤133umol/L ) . 7 . Patient 's remain lifetime expect least 3 month . 1 . Hepatocellular carcinoma transfer pathological/ radiological test ( Stage III Stage IV , refer exhibit 10 ) 2 . The carcinoma invade main portal vein major branch hepatic vein 3 . ChildPugh score 6 4 . Patient serious problem pulmonary function sub investigator 's opinion 5 . Patient disease history immune deficiency 6 . Diagnosed immune deficiency patient 7 . Patient disease history malignant tumor within 5 year clinical trial . 8 . Patient anticancer medication clinical trial 9 . Patient serious allergichistory sub investigator 's opinion 10 . Patient serious mental disease sub investigator 's opinion 11 . Pregnant woman , nurse mother intention pregnant clinical test 12 . Patient participate clinical trial within 4 week clinical trial 13 . Patient incongruent clinical trial sub investigator 's opinion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Hepatocellular Carcinoma</keyword>
	<keyword>Natural Killer cell</keyword>
</DOC>